Company research / SIGY
Sigyn Therapeutics, Inc. (SIGY)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2019-12-31, Sigyn Therapeutics, Inc. reported revenue of $143.3K. Revenue grew 405.6% from the prior annual period.
Key ratios (year ended 2019-12-31)
75.1%
Gross margin
-361.4%
Operating margin
-2145.3%
Net margin
405.6%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.